Screening of Nutritional Status in Cardiac Surgery
1 other identifier
observational
1,210
1 country
1
Brief Summary
Screening of nutritional status is unsolved problem in cardiac surgery. Applicability of such criteria as body mass index and albumin and screening scales (MNA, NRS-2002, SGA, SNAQ) in cardiac surgery is controversial and insufficiently studied. Furthermore, there is some known predictors of poor outcome, which closely related to nutritional status (C-reactive protein, total lymphocyte count). The aim of this study is assessment of several nutritional screening scales, objective nutritional criteria and predictors for the purpose of detection of most informative one or its combination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 31, 2011
CompletedFirst Posted
Study publicly available on registry
June 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedJanuary 18, 2020
January 1, 2020
2.8 years
May 31, 2011
January 16, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality
Participants will be followed for the duration of hospital stay, an average of 4 weeks.
Secondary Outcomes (4)
Complications
Participants will be followed for the duration of hospital stay, an average of 4 weeks.
Intensive care unit stay
Participants will be followed for the duration of hospital stay, an average of 4 weeks.
Hospital stay
Participants will be followed for the duration of hospital stay, an average of 4 weeks.
Ventilation time
Participants will be followed for the duration of hospital stay, an average of 4 weeks.
Eligibility Criteria
Patients, who live in Russia, mostly in Siberia whom scheduled to cardiac surgery in one institution.
You may qualify if:
- Adult patients with cardiovascular disease operated on under cardiopulmonary bypass
You may not qualify if:
- Age under 18 years
- Emergency
- Participation in other trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Novosibirsk Research Institute of Patholgy of Circulation
Novosibirsk, 630055, Russia
Related Publications (2)
Lomivorotov VV, Efremov SM, Boboshko VA, Leyderman IN, Lomivorotov VN, Cheung AT, Karaskov AM. Preoperative total lymphocyte count in peripheral blood as a predictor of poor outcome in adult cardiac surgery. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):975-80. doi: 10.1053/j.jvca.2010.12.006. Epub 2011 Feb 26.
PMID: 21354824BACKGROUNDLomivorotov VV, Efremov SM, Boboshko VA, Nikolaev DA, Vedernikov PE, Lomivorotov VN, Karaskov AM. Evaluation of nutritional screening tools for patients scheduled for cardiac surgery. Nutrition. 2013 Feb;29(2):436-42. doi: 10.1016/j.nut.2012.08.006. Epub 2012 Nov 27.
PMID: 23200301RESULT
Biospecimen
Serum, white cells
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Vladimir V Lomivorotov, MD, PhD
Novosibirsk Research Institute of Pathology of Circulation
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesist
Study Record Dates
First Submitted
May 31, 2011
First Posted
June 6, 2011
Study Start
January 1, 2011
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
January 18, 2020
Record last verified: 2020-01